Filing Details

Accession Number:
0001127602-20-031563
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-16 16:36:43
Reporting Period:
2020-12-15
Accepted Time:
2020-12-16 16:36:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492422 Apellis Pharmaceuticals Inc. APLS Pharmaceutical Preparations (2834) 271537290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1496687 Alec Machiels C/O Apellis Pharmaceuticals, Inc.
100 Fifth Avenue, 3Rd Floor
Waltham MA 02451
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-15 2,500 $2.67 672,044 No 4 M Direct
Common Stock Disposition 2020-12-15 2,500 $52.16 669,544 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-12-15 2,500 $0.00 2,500 $2.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
157,529 2023-12-04 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,950 Indirect See Footnote
Footnotes
  1. This is a scheduled exercise from 10B5-1 trading plan.
  2. Owned by spouse.
  3. This option was granted on December 5, 2013 and fully vested.